Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine

(Daniel Schludi, Unsplash)

This article is brought to you in association with the European Commission.


Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19.

Today’s contract with CureVac enlarges the already broad portfolio of vaccines to be produced in Europe, including the contracts signed with AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV and BioNtech-Pfizer, and the successful exploratory talks with Moderna. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective. Member States can also decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

President of the European Commission, Ursula von der Leyen, said:  “A few days after our contract with BioNTech and Pfizer, I am delighted to announce a new agreement with a promising European company. The Commission has secured to date at least 1.2 billion doses and fulfils its commitment to ensuring equitable access to safe, effective and affordable vaccines not only for EU citizens but also for the world’s poorest and most vulnerable people. Most of these vaccine candidates are in an advanced phase of clinical trials, hopefully authorisation will confirm these positive results, after which they will be quickly deployed and help us in overcoming the pandemic.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “With growing numbers of COVID patients across the EU, a safe and effective vaccine is more crucial than ever in putting behind us the pandemic. With this fifth vaccine advance purchase agreement, we are further expanding the possibilities that EU citizens and our economies can soon safely return to normality. It is yet another milestone in our EU Vaccines Strategy, and evidence of the benefits of working together in a genuine European Health Union.”

CureVac, a European company based in Germany, signed a €75 million loan agreement with the European Investment Bank on 6 July for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against COVID-19. CureVac is pioneering the development of a completely new class of vaccines based on messenger RNA (mRNA), transported into cells by lipid nanoparticles. The vaccine platform has been developed over the last decade. The basic principle is the use of this molecule as a data carrier for information, with the help of which the body itself can produce its own active substances to combat various diseases.

The Commission has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company’s experience in vaccine development and its production capacity to supply the whole of the EU.

Background

The European Commission presented on 17 June a European strategy to accelerate the development, manufacturing and deployment of effective and safe vaccines against COVID-19. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission finances part of the upfront costs faced by vaccines producers in the form of Advance Purchase Agreements. Funding provided is considered as a down-payment on the vaccines that will actually be purchased by Member States.

Since the high cost and high failure rate make investing in a COVID-19 vaccine a high-risk decision for vaccine developers, these agreements will therefore allow investments to be made that otherwise might not happen.

Once vaccines have been proven to be safe and effective and have been granted market authorisation by the European Medicines Agency, they need to be quickly distributed and deployed across Europe. On 15 October, the Commission set out the key steps that Member States need to take to be fully prepared, which includes the development of national vaccination strategies. The Commission is putting in place a common reporting framework and a platform to monitor the effectiveness of national vaccine strategies.

The European Commission is also committed to ensuring that everyone who needs a vaccine gets it, anywhere in the world and not only at home. No one will be safe until everyone is safe. This is why it has raised almost €16 billion since 4 May 2020 under the Coronavirus Global Response, the global action for universal access to tests, treatments and vaccines against coronavirus and for the global recovery and has confirmed its interest to participate in the COVAX Facility for equitable access to affordable COVID-19 vaccines everywhere. As part of a Team Europe effort, the Commission announced is contributing with €400 million in guarantees to support COVAX and its objectives in the context of the Coronavirus Global Response. On 12 November, the European Union announced the contribution of an additional €100 million in grant funding to support the COVAX Facility.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

ILO’s Bureau for Employers´Activities to publish new study on women in business and management

MEPs adopt revised rules for road haulage operations in another EU country

Cholera surges, children in urgent need one month after Cyclone Idai slammed southern Africa – UNICEF

MEPs adopt new Fisheries Partnership with Morocco including Western Sahara

‘World’s deadliest sea crossing’ claimed six lives a day in 2018: UN refugee agency

Commission issues guidance on the participation of third country bidders in the EU procurement market

Draghi to lay his print on long term ECB policies prior to exiting next year

MEPs to grill Frontex director on agency’s role in pushbacks of asylum-seekers

Inequality in the delivery of health services

‘New tech’ business model threatens decent work conditions, warns UN

Risks rising in corporate debt market

Is euro to repeat its past highs with the dollar?

These are the countries with the highest inflation

Islamophobia is driving more US Muslims to become politically engaged, suggests report

5 ways to go green in your own kitchen

This is what different countries are doing to stop coronavirus from spreading

Central Asia: the European Union matches political commitment with further concrete support

Data and the future of financial services

UN agency chief calls Ethiopia’s revised refugee law ‘one of most progressive’ in Africa

An electric motorbike could help tackle big game poaching. Here’s how

The relation of deforestation and respiratory diseases

Central Mali: Top UN genocide prevention official sounds alarm over recent ethnically-targeted killings

How women are transforming the Arab world’s start-up scene

Fifth-generation cyberattacks are here. How can the IT industry adapt?

Terrorist content online should be removed within one hour, says EP

MEPs: Access to adequate housing should be a fundamental European right

FROM THE FIELD: Faces and Voices of Conflict

Why the world is not as globalized as you think

Solidarity Fund: €823 million in EU aid for eight member states

Coronavirus: the truth against the myths

A Sting Exclusive: EU Commission’s Vice President Šefčovič accentuates the importance of innovation to EU’s Energy Union

Trade: EU and 16 WTO members agree to work together on an interim appeal arbitration arrangement

Draghi’s negative interest rates help Eurozone’s cohesion

Gender Science: A sneaky healthcare risk factor

Stage set for successful 2020 Burundi elections, Foreign Minister tells General Assembly

Use space technology to build a better world for all, urges UN chief

‘Preserve, revitalize and promote’ indigenous languages, or lose a ‘wealth of traditional knowledge’, UN chief says

HPV vaccine: the silver bullet that saves women

Top UN officials sound alarm as Yemen fighting nears vital hospital in port city of Hudaydah

The city of Quito just made commuting quicker and safer

These 4 Nordic countries hold the secret to gender equality

Jo Cox’s murderer believed the ‘leave’ campaign leaders that the ‘remain’ vote is treason

Dangers of poor quality health care revealed ‘in all countries’: WHO report

Catalan Pro-Independence vote: how many hits can Brussels sustain at the same time?

In wake of ‘collapsed’ agreement, new wave of violence threatens millions in Syria’s Idlib

LGBTQI+ and medicine

Why carbon capture could be the game-changer the world needs

Christmas spending: Who can afford not to cut?

Promoting Health in the Brazilian Amazon: one nation but many cultures

Tropical Cyclone Idai affects 1.5 million across Mozambique and Malawi, as UN ramps up response

How young people can help respond to the coronavirus outbreak

The Great Reset requires FinTechs – and FinTechs require a common approach to cybersecurity

How curiosity and globalization are driving a new approach to travel

Political consensus critical ahead of Somalia election: UN mission chief

MEPs call for sanctions against Turkey over military operation in Syria

Will technology connect or divide us? The challenge for leaders in Globalization 4.0

COVID-19 threatens the developing world’s small businesses. This is how to save them

Is the ECB ready to flood Eurozone with freshly printed money?

EU–US: What is the real exchange in a Free Trade Agreement?

The world needs a circular economy. Help us make it happen

More Stings?

Advertising

Trackbacks

  1. […] Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine – […]

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s